| UniProt ID | IRF3_MOUSE | |
|---|---|---|
| UniProt AC | P70671 | |
| Protein Name | Interferon regulatory factor 3 | |
| Gene Name | Irf3 | |
| Organism | Mus musculus (Mouse). | |
| Sequence Length | 419 | |
| Subcellular Localization | Cytoplasm . Nucleus . Shuttles between cytoplasmic and nuclear compartments, with export being the prevailing effect. When activated, IRF3 interaction with CREBBP prevents its export to the cytoplasm. | |
| Protein Description | Key transcriptional regulator of type I interferon (IFN)-dependent immune responses which plays a critical role in the innate immune response against DNA and RNA viruses. Regulates the transcription of type I IFN genes (IFN-alpha and IFN-beta) and IFN-stimulated genes (ISG) by binding to an interferon-stimulated response element (ISRE) in their promoters. Acts as a more potent activator of the IFN-beta (IFNB) gene than the IFN-alpha (IFNA) gene and plays a critical role in both the early and late phases of the IFNA/B gene induction. Found in an inactive form in the cytoplasm of uninfected cells and following viral infection, double-stranded RNA (dsRNA), or toll-like receptor (TLR) signaling, is phosphorylated by IKBKE and TBK1 kinases. This induces a conformational change, leading to its dimerization and nuclear localization and association with CREB binding protein (CREBBP) to form dsRNA-activated factor 1 (DRAF1), a complex which activates the transcription of the type I IFN and ISG genes. Can activate distinct gene expression programs in macrophages and can induce significant apoptosis in primary macrophages.. | |
| Protein Sequence | METPKPRILPWLVSQLDLGQLEGVAWLDESRTRFRIPWKHGLRQDAQMADFGIFQAWAEASGAYTPGKDKPDVSTWKRNFRSALNRKEVLRLAADNSKDPYDPHKVYEFVTPGARDFVHLGASPDTNGKSSLPHSQENLPKLFDGLILGPLKDEGSSDLAIVSDPSQQLPSPNVNNFLNPAPQENPLKQLLAEEQWEFEVTAFYRGRQVFQQTLFCPGGLRLVGSTADMTLPWQPVTLPDPEGFLTDKLVKEYVGQVLKGLGNGLALWQAGQCLWAQRLGHSHAFWALGEELLPDSGRGPDGEVHKDKDGAVFDLRPFVADLIAFMEGSGHSPRYTLWFCMGEMWPQDQPWVKRLVMVKVVPTCLKELLEMAREGGASSLKTVDLHISNSQPISLTSDQYKAYLQDLVEDMDFQATGNI | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----METPKPRILP -----CCCCCCCCHH | 35.00 | - | |
| 14 | Phosphorylation | RILPWLVSQLDLGQL CCHHHHHHHCCCCCC | 23.90 | - | |
| 74 | Phosphorylation | GKDKPDVSTWKRNFR CCCCCCHHHHHHHHH | 35.61 | 25338131 | |
| 75 | Phosphorylation | KDKPDVSTWKRNFRS CCCCCHHHHHHHHHH | 34.55 | - | |
| 77 | Malonylation | KPDVSTWKRNFRSAL CCCHHHHHHHHHHHH | 37.24 | 26320211 | |
| 87 | Ubiquitination | FRSALNRKEVLRLAA HHHHHCHHHHHHHHH | 51.61 | - | |
| 97 | Phosphorylation | LRLAADNSKDPYDPH HHHHHCCCCCCCCHH | 38.70 | - | |
| 105 | Acetylation | KDPYDPHKVYEFVTP CCCCCHHHHEEEECC | 52.48 | 23954790 | |
| 105 | Malonylation | KDPYDPHKVYEFVTP CCCCCHHHHEEEECC | 52.48 | 26320211 | |
| 107 | Phosphorylation | PYDPHKVYEFVTPGA CCCHHHHEEEECCCC | 14.41 | 25367039 | |
| 111 | Phosphorylation | HKVYEFVTPGARDFV HHHEEEECCCCCCCE | 22.71 | 23984901 | |
| 123 | Phosphorylation | DFVHLGASPDTNGKS CCEECCCCCCCCCCC | 22.85 | 25521595 | |
| 126 | Phosphorylation | HLGASPDTNGKSSLP ECCCCCCCCCCCCCC | 49.62 | 21082442 | |
| 130 | Phosphorylation | SPDTNGKSSLPHSQE CCCCCCCCCCCCCCC | 38.21 | 27087446 | |
| 131 | Phosphorylation | PDTNGKSSLPHSQEN CCCCCCCCCCCCCCC | 49.78 | 27087446 | |
| 135 | Phosphorylation | GKSSLPHSQENLPKL CCCCCCCCCCCHHHH | 36.93 | 27087446 | |
| 152 | Sumoylation | GLILGPLKDEGSSDL CEEEECCCCCCCCCE | 57.79 | - | |
| 152 | Sumoylation | GLILGPLKDEGSSDL CEEEECCCCCCCCCE | 57.79 | - | |
| 171 | Phosphorylation | DPSQQLPSPNVNNFL CHHHCCCCCCCCCCC | 37.38 | 30352176 | |
| 230 | Phosphorylation | VGSTADMTLPWQPVT ECEECCEECCCCCCC | 30.16 | - | |
| 237 | Phosphorylation | TLPWQPVTLPDPEGF ECCCCCCCCCCCCCC | 38.98 | - | |
| 246 | Phosphorylation | PDPEGFLTDKLVKEY CCCCCCCCHHHHHHH | 28.91 | - | |
| 332 | Phosphorylation | FMEGSGHSPRYTLWF HHHCCCCCCCCEEEE | 18.01 | - | |
| 366 | Ubiquitination | KVVPTCLKELLEMAR HHHHHHHHHHHHHHH | 48.76 | 22790023 | |
| 378 | Phosphorylation | MAREGGASSLKTVDL HHHHCCCCCCEEEEE | 39.21 | 30352176 | |
| 379 | Phosphorylation | AREGGASSLKTVDLH HHHCCCCCCEEEEEE | 33.09 | 27149854 | |
| 382 | Phosphorylation | GGASSLKTVDLHISN CCCCCCEEEEEEECC | 25.25 | 24719451 | |
| 388 | Phosphorylation | KTVDLHISNSQPISL EEEEEEECCCCCCCC | 21.49 | 28725479 | |
| 390 | Phosphorylation | VDLHISNSQPISLTS EEEEECCCCCCCCCH | 30.46 | - | |
| 396 | Phosphorylation | NSQPISLTSDQYKAY CCCCCCCCHHHHHHH | 24.38 | 21106850 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IRF3_MOUSE !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IRF3_MOUSE !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TRI26_MOUSE | Trim26 | physical | 25763818 |
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-123 AND SER-135, ANDMASS SPECTROMETRY. | |